Bristol-Myers Squibb and Ono Pharmaceutical have sued Merck, alleging Merck's new cancer drug Keytruda violates their patent for a method of harnessing the body's immune system to fight cancer.
via WSJ.com: US Business http://ift.tt/1qFLvP0
via WSJ.com: US Business http://ift.tt/1qFLvP0
Nessun commento:
Posta un commento